Weiss Multi-Strategy Advisers LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$43
-32.8%
31,814
-10.5%
0.00%0.0%
Q2 2023$64
-58.2%
35,559
-9.5%
0.00%
-75.0%
Q1 2023$153
+86.6%
39,312
+62.9%
0.00%
+100.0%
Q4 2022$82
-99.9%
24,129
-2.4%
0.00%
-50.0%
Q3 2022$135,000
+17.4%
24,725
-3.1%
0.00%
+33.3%
Q2 2022$115,000
-43.9%
25,522
-8.5%
0.00%
-40.0%
Q1 2022$205,000
+6.8%
27,878
-6.7%
0.01%
+25.0%
Q4 2021$192,000
-3.0%
29,883
-12.4%
0.00%0.0%
Q3 2021$198,000
-42.4%
34,099
+2.3%
0.00%
-50.0%
Q2 2021$344,000
+1.8%
33,337
+3.7%
0.01%
+14.3%
Q1 2021$338,000
-12.9%
32,143
+28.1%
0.01%0.0%
Q4 2020$388,000
+20.1%
25,096
+13.4%
0.01%
-22.2%
Q3 2020$323,000
+58.3%
22,139
+108.8%
0.01%
+12.5%
Q1 2020$204,000
-29.2%
10,604
-29.3%
0.01%
+60.0%
Q4 2019$288,000
+19.5%
15,000
-40.0%
0.01%0.0%
Q3 2019$241,000
+60.7%
25,0000.0%0.01%
+25.0%
Q2 2019$150,000
+2.7%
25,0000.0%0.00%0.0%
Q1 2019$146,000
-37.6%
25,0000.0%0.00%
-60.0%
Q4 2018$234,000
-31.6%
25,000
+24.4%
0.01%
+11.1%
Q3 2018$342,000
+0.6%
20,095
+0.5%
0.01%
+12.5%
Q2 2018$340,00020,0000.01%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders